You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2025

List of Excipients in API prucalopride


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing prucalopride

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Takeda Pharmaceuticals America Inc MOTEGRITY prucalopride 54092-546 CELLULOSE, MICROCRYSTALLINE
Takeda Pharmaceuticals America Inc MOTEGRITY prucalopride 54092-546 HYPROMELLOSE 2910
Takeda Pharmaceuticals America Inc MOTEGRITY prucalopride 54092-546 LACTOSE MONOHYDRATE
Takeda Pharmaceuticals America Inc MOTEGRITY prucalopride 54092-546 MAGNESIUM STEARATE
Takeda Pharmaceuticals America Inc MOTEGRITY prucalopride 54092-546 POLYETHYLENE GLYCOL 3000
Takeda Pharmaceuticals America Inc MOTEGRITY prucalopride 54092-546 SILICON DIOXIDE
Takeda Pharmaceuticals America Inc MOTEGRITY prucalopride 54092-546 TITANIUM DIOXIDE
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Get Started Free

Excipients in ANDA-approved (generic) drugs containing prucalopride

Company Ingredient NDC Excipient
Hikma Pharmaceuticals USA Inc prucalopride 0054-0749 CELLULOSE, MICROCRYSTALLINE
Hikma Pharmaceuticals USA Inc prucalopride 0054-0749 HYPROMELLOSE 2910
Hikma Pharmaceuticals USA Inc prucalopride 0054-0749 MAGNESIUM STEARATE
Hikma Pharmaceuticals USA Inc prucalopride 0054-0749 MANNITOL
Hikma Pharmaceuticals USA Inc prucalopride 0054-0749 POLYDEXTROSE
Hikma Pharmaceuticals USA Inc prucalopride 0054-0749 POLYETHYLENE GLYCOL 8000
Hikma Pharmaceuticals USA Inc prucalopride 0054-0749 SILICON DIOXIDE
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Get Started Free

Detailed excipient profiles for prucalopride

Excipient focus: ANHYDROUS LACTOSE

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: CROSPOVIDONE

Excipient focus: FERRIC OXIDE YELLOW

Excipient focus: HYDROXYPROPYL CELLULOSE

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSE 2910

Excipient focus: HYPROMELLOSES

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: MAGNESIUM STEARATE

Excipient focus: MANNITOL

Excipient focus: MICROCRYSTALLINE CELLULOSE 102

Excipient focus: MICROCRYSTALLINE CELLULOSE 112

Excipient focus: POLYDEXTROSE

Excipient focus: POLYETHYLENE GLYCOL

Excipient focus: POLYETHYLENE GLYCOL 3000

prucalopride drug variants not containing POLYETHYLENE GLYCOL 3000

Company Ingredient NDC
Hikma Pharmaceuticals USA Inc prucalopride 0054-0749
SpecGx LLC prucalopride 0406-6301
Camber Pharmaceuticals Inc prucalopride 31722-391
Apotex Corp prucalopride 60505-4806
Amneal Pharmaceuticals NY LLC prucalopride 69238-2698
Lupin Pharmaceuticals Inc prucalopride 70748-389
Novadoz Pharmaceuticals LLC prucalopride 72205-218
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: POLYETHYLENE GLYCOL 3350

Excipient focus: POLYETHYLENE GLYCOL 4000

Excipient focus: POLYETHYLENE GLYCOL 8000

Excipient focus: SILICON DIOXIDE

Excipient focus: TALC

Excipient focus: TITANIUM DIOXIDE

Excipient focus: TRIACETIN

Excipient focus: TRIETHYL CITRATE

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
 NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links